Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,395.00    -60.00 (-1.10%)
Bid:
5,390.00
Ask:
5,400.00
Spread: 10.00 (0.186%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

18 Oct 2012 10:30

RNS Number : 9885O
Renishaw PLC
18 October 2012
 



Renishaw plc

Interim management statement

 

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2012. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

I am pleased to report that as we expected there was strong growth for the three months to 30th September 2012, with revenue achieving a first quarter record of £95.9m, an increase of £25.4m, or 36%, over the £70.5m for the first quarter of the previous year.

 

By business segment, our metrology business reported revenue growth of 38% ahead of last year reflecting major sales to the consumer electronics industry and our healthcare revenue was at a similar level to the comparable period last year.

 

Geographically, the Far East, specifically China, more than doubled its revenue for this quarter compared to the corresponding period last year. Revenue for Europe and the Americas were broadly in line with last year and the UK, a smaller geographical area in terms of revenue, showed a 27% increase.

 

 

The Group cost base has continued to increase with additional, mainly engineering, staff to support its growing revenue and demand for production resource, along with increasing investment in its research and development programmes. Group headcount at the end of September 2012 was 3,018, an increase of 114 from the 2,904 at the start of the financial year at 1st July 2012.

 

Profit before tax for the first quarter amounted to £28.3m, compared with £13.6m last year, an increase of £14.7m, or 108%.

 

Significant events and financial position

On 10th October 2012, the Company held the official opening of its manufacturing facility at Miskin, South Wales, where 68,500 square feet has been refurbished and is operational.

 

There has been no significant capital expenditure or any other significant events during the period.

 

The Group balance sheet remains strong with net cash balances, excluding the escrow account relating to security for the UK defined benefit pension scheme, at 30th September 2012 of £18.4m (30th June 2012 £21.1m).

 

As David Snowden and Terry Garthwaite have each completed nine years on the Board, they will not be seeking re-election at the AGM today. The Board is very grateful for their considerable contributions to the Group.

 

As announced on 10th October 2012 Carol Chesney, a chartered accountant and company secretary at the manufacturing group Halma plc, will be joining the Board on 19th October 2012 as non-executive director and chair of the Audit Committee. Dr David Grant has been appointed the chair of the Remuneration Committee in place of David Snowden.

 

I should like to thank our staff for their continuing efforts and support.

 

Outlook

We have had a strong start to the year, however it is still very early in our financial year and the order book remains at approximately one month's revenue. There is still much uncertainty surrounding worldwide economic growth rates. With the Group's broad geographical market coverage however and focus on global investment in production systems and processes, the Board remains confident of a further year of progress.

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

18th October 2012

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMPBLTMBBBMIT
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.